Share Price and Basic Stock Data
Last Updated: December 27, 2025, 10:14 pm
| PEG Ratio | -2.74 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Uniphos Enterprises Ltd, with a current market capitalization of ₹988 Cr, has exhibited a fluctuating revenue profile over recent years. The company reported a total sales figure of ₹1 Cr for the fiscal year ending March 2023, a stark contrast to projected revenues of ₹112 Cr for March 2025. The revenue trajectory shows a notable increase in the upcoming quarters, with sales expected to rise from ₹50.65 Cr in March 2024 to ₹72.90 Cr in March 2025. This represents a significant shift from the previous fiscal years where sales were either zero or minimal, highlighting a potential recovery phase for the company as it seeks to stabilize its operations. The operating profit margin (OPM) stood at -14.33%, indicating challenges in managing costs effectively. However, with a robust reserve of ₹2,831 Cr, the company appears to have a solid financial cushion to support its operational turnaround and growth initiatives.
Profitability and Efficiency Metrics
Uniphos has grappled with profitability challenges, as reflected in its operating profit, which has consistently reported negative figures over the years. For instance, the operating profit for March 2025 is forecasted to be -₹4 Cr, while net profit for the same period showed a drastic decline to ₹0.04 Cr, down from ₹5.55 Cr in March 2024. The company has maintained a low return on equity (ROE) of 0.01% and return on capital employed (ROCE) of 0.06%, both indicating inefficiencies in generating returns relative to shareholder equity and capital employed. Moreover, the interest coverage ratio (ICR) of 1.75x suggests that while the company can cover its interest obligations, the margin is slim. The poor OPM reflects operational inefficiencies that need to be addressed for improved financial health. The trajectory of profitability remains a critical area for stakeholders to monitor as the company navigates its recovery path.
Balance Sheet Strength and Financial Ratios
The balance sheet of Uniphos Enterprises presents a mixed picture. The company holds reserves of ₹2,831 Cr against minimal borrowings of ₹1 Cr, indicating a strong capital position with low leverage. This low debt level provides a buffer against financial stress; however, the current ratio of 8.83x signals an excessive liquidity position, potentially indicating inefficiencies in utilizing assets for growth. The price-to-book value ratio (P/BV) stands at 0.41x, suggesting that the market values the company below its book value, which may reflect investor skepticism regarding future profitability. Furthermore, the net profit margin of 0.24% and a cash earning retention ratio that has turned negative (-14,144.01%) raises concerns about the company’s ability to reinvest earnings effectively. Overall, while the balance sheet showcases financial resilience, the underlying profitability issues necessitate strategic operational improvements.
Shareholding Pattern and Investor Confidence
Uniphos Enterprises exhibits a stable shareholding pattern, with promoters holding 73.79% of the equity, indicating significant insider confidence in the company’s future. Foreign institutional investors (FIIs) have a stake of 15.71%, which reflects a moderate level of external confidence. However, the lack of domestic institutional investors (DIIs) may suggest a cautious approach from local entities towards the company’s recovery prospects. The total number of shareholders has increased to 12,699, indicating growing interest among retail investors, although the public shareholding remains relatively low at 10.50%. This concentration of ownership implies that the company may benefit from strategic initiatives led by promoters, yet it also raises concerns about potential governance issues if performance does not improve. The stability in shareholding may provide a foundation for long-term growth, provided the company can convert its operational challenges into profitable outcomes.
Outlook, Risks, and Final Insight
The outlook for Uniphos Enterprises hinges on its ability to convert recent sales increases into sustainable profitability. Key strengths include a strong reserve base of ₹2,831 Cr and low debt levels, which offer financial flexibility. However, significant risks remain, including ongoing operational inefficiencies reflected in negative profit margins and low ROE and ROCE ratios. The company must address these profitability challenges to regain investor confidence and improve its market valuation. If Uniphos can successfully implement operational improvements and leverage its substantial reserves for growth initiatives, it may enhance its financial performance. Conversely, failure to address these issues could hinder recovery efforts, potentially leading to further declines in profitability and market perception. Stakeholders should closely monitor the company’s strategic execution in the coming quarters to gauge its recovery trajectory.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat Metallic Coal & Coke Ltd | 5.94 Cr. | 30.0 | / | 77.6 | 0.00 % | 0.37 % | 2.00 % | 100 | |
| Gensol Engineering Ltd | 103 Cr. | 26.9 | 796/25.8 | 1.01 | 155 | 0.00 % | 14.3 % | 22.4 % | 10.0 |
| Fusion Micro Finance Ltd | 1,626 Cr. | 161 | 212/124 | 118 | 0.00 % | 2.96 % | 54.5 % | 10.0 | |
| Five X Tradecom Ltd | 0.99 Cr. | 0.48 | / | 9.35 | 0.00 % | 0.00 % | 0.00 % | 10.0 | |
| East West Holdings Ltd | 45.4 Cr. | 3.56 | 8.59/3.48 | 4.93 | 0.00 % | 6.98 % | 0.86 % | 2.00 | |
| Industry Average | 7,628.43 Cr | 221.96 | 391.60 | 219.27 | 0.25% | 11.73% | 22.92% | 9.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 1.47 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 50.65 | 3.03 | 30.48 | 5.10 | 72.90 | 5.86 |
| Expenses | 0.65 | 2.25 | 0.71 | 0.73 | 0.79 | 0.75 | 0.69 | 51.51 | 3.78 | 30.96 | 6.10 | 74.50 | 6.70 |
| Operating Profit | -0.65 | -0.78 | -0.71 | -0.73 | -0.79 | -0.75 | -0.69 | -0.86 | -0.75 | -0.48 | -1.00 | -1.60 | -0.84 |
| OPM % | -53.06% | -1.70% | -24.75% | -1.57% | -19.61% | -2.19% | -14.33% | ||||||
| Other Income | 0.79 | 40.28 | 0.87 | 1.15 | 0.91 | 40.44 | 0.87 | 0.65 | 0.79 | 4.67 | 0.45 | 0.21 | 0.27 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.14 | 1.17 | 0.00 | 0.00 |
| Depreciation | 0.01 | 0.15 | 0.22 | 0.22 | 0.21 | 0.21 | 0.21 | 0.21 | 0.19 | 0.19 | 0.19 | 0.19 | 0.17 |
| Profit before tax | 0.13 | 39.35 | -0.06 | 0.20 | -0.09 | 39.48 | -0.03 | -0.42 | -0.15 | 3.86 | -1.91 | -1.58 | -0.74 |
| Tax % | 0.00% | 0.13% | 1,016.67% | -135.00% | 0.00% | 0.30% | 0.00% | 50.00% | 0.00% | 0.00% | -2.62% | 0.00% | 0.00% |
| Net Profit | 0.13 | 39.30 | -0.67 | 0.47 | -0.08 | 39.36 | -0.03 | -0.63 | -0.15 | 3.86 | -1.86 | -1.58 | -0.74 |
| EPS in Rs | 0.02 | 5.65 | -0.10 | 0.07 | -0.01 | 5.66 | -0.00 | -0.09 | -0.02 | 0.56 | -0.27 | -0.23 | -0.11 |
Last Updated: August 20, 2025, 1:50 am
Below is a detailed analysis of the quarterly data for Uniphos Enterprises Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 5.86 Cr.. The value appears to be declining and may need further review. It has decreased from 72.90 Cr. (Mar 2025) to 5.86 Cr., marking a decrease of 67.04 Cr..
- For Expenses, as of Jun 2025, the value is 6.70 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 74.50 Cr. (Mar 2025) to 6.70 Cr., marking a decrease of 67.80 Cr..
- For Operating Profit, as of Jun 2025, the value is -0.84 Cr.. The value appears strong and on an upward trend. It has increased from -1.60 Cr. (Mar 2025) to -0.84 Cr., marking an increase of 0.76 Cr..
- For OPM %, as of Jun 2025, the value is -14.33%. The value appears to be declining and may need further review. It has decreased from -2.19% (Mar 2025) to -14.33%, marking a decrease of 12.14%.
- For Other Income, as of Jun 2025, the value is 0.27 Cr.. The value appears strong and on an upward trend. It has increased from 0.21 Cr. (Mar 2025) to 0.27 Cr., marking an increase of 0.06 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 0.17 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.19 Cr. (Mar 2025) to 0.17 Cr., marking a decrease of 0.02 Cr..
- For Profit before tax, as of Jun 2025, the value is -0.74 Cr.. The value appears strong and on an upward trend. It has increased from -1.58 Cr. (Mar 2025) to -0.74 Cr., marking an increase of 0.84 Cr..
- For Tax %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
- For Net Profit, as of Jun 2025, the value is -0.74 Cr.. The value appears strong and on an upward trend. It has increased from -1.58 Cr. (Mar 2025) to -0.74 Cr., marking an increase of 0.84 Cr..
- For EPS in Rs, as of Jun 2025, the value is -0.11. The value appears strong and on an upward trend. It has increased from -0.23 (Mar 2025) to -0.11, marking an increase of 0.12.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:27 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 9 | 2 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 51 | 112 | 84 |
| Expenses | 10 | 3 | 1 | 2 | 2 | 3 | 2 | 4 | 4 | 4 | 54 | 115 | 88 |
| Operating Profit | -1 | -1 | -1 | -2 | -2 | -3 | -2 | -3 | -3 | -3 | -3 | -4 | -5 |
| OPM % | -6% | -47% | -987% | -370% | -257% | -195% | -6% | -3% | -5% | ||||
| Other Income | 7 | 11 | 14 | 13 | 20 | 24 | 23 | 26 | 57 | 43 | 43 | 6 | 25 |
| Interest | 8 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| Profit before tax | -2 | 9 | 12 | 11 | 18 | 21 | 20 | 23 | 54 | 40 | 39 | 0 | 19 |
| Tax % | 0% | 0% | 0% | 0% | 2% | 2% | 2% | -4% | -1% | 1% | 1% | -22% | |
| Net Profit | -2 | 9 | 12 | 11 | 18 | 21 | 20 | 24 | 55 | 39 | 39 | 0 | 19 |
| EPS in Rs | -0.23 | 1.23 | 1.70 | 1.62 | 2.54 | 2.99 | 2.89 | 3.52 | 7.85 | 5.64 | 5.55 | 0.04 | 2.72 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 97% | 72% | 115% | 103% | 1,242% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 550.00% | 33.33% | -8.33% | 63.64% | 16.67% | -4.76% | 20.00% | 129.17% | -29.09% | 0.00% | -100.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -516.67% | -41.67% | 71.97% | -46.97% | -21.43% | 24.76% | 109.17% | -158.26% | 29.09% | -100.00% |
Uniphos Enterprises Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 50% |
| 5 Years: | 244% |
| 3 Years: | 350% |
| TTM: | 113% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -29% |
| 5 Years: | -58% |
| 3 Years: | -83% |
| TTM: | -101% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 18% |
| 3 Years: | 5% |
| 1 Year: | -20% |
| Return on Equity | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 1% |
| 3 Years: | 1% |
| Last Year: | 0% |
Last Updated: September 5, 2025, 1:50 pm
Balance Sheet
Last Updated: December 10, 2025, 3:36 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 |
| Reserves | 249 | 258 | 270 | 2,053 | 2,076 | 2,684 | 1,504 | 2,701 | 3,167 | 2,984 | 2,062 | 2,728 | 2,831 |
| Borrowings | 10 | 10 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 1 |
| Other Liabilities | 7 | 0 | 0 | 0 | 0 | 0 | 1 | 57 | 121 | 98 | 2 | 100 | 117 |
| Total Liabilities | 281 | 282 | 284 | 2,067 | 2,090 | 2,698 | 1,519 | 2,772 | 3,302 | 3,095 | 2,078 | 2,842 | 2,962 |
| Fixed Assets | 174 | 174 | 174 | 175 | 175 | 175 | 175 | 176 | 176 | 184 | 183 | 182 | 182 |
| CWIP | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Investments | 84 | 84 | 84 | 1,856 | 1,871 | 2,483 | 1,261 | 2,550 | 3,080 | 2,856 | 1,802 | 2,616 | 2,735 |
| Other Assets | 23 | 24 | 26 | 36 | 44 | 40 | 83 | 46 | 46 | 55 | 92 | 44 | 46 |
| Total Assets | 281 | 282 | 284 | 2,067 | 2,090 | 2,698 | 1,519 | 2,772 | 3,302 | 3,095 | 2,078 | 2,842 | 2,962 |
Below is a detailed analysis of the balance sheet data for Uniphos Enterprises Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 14.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 14.00 Cr..
- For Reserves, as of Sep 2025, the value is 2,831.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,728.00 Cr. (Mar 2025) to 2,831.00 Cr., marking an increase of 103.00 Cr..
- For Borrowings, as of Sep 2025, the value is 1.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 0.00 Cr. (Mar 2025) to 1.00 Cr., marking an increase of 1.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 117.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 100.00 Cr. (Mar 2025) to 117.00 Cr., marking an increase of 17.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 2,962.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,842.00 Cr. (Mar 2025) to 2,962.00 Cr., marking an increase of 120.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 182.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 182.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 2,735.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,616.00 Cr. (Mar 2025) to 2,735.00 Cr., marking an increase of 119.00 Cr..
- For Other Assets, as of Sep 2025, the value is 46.00 Cr.. The value appears strong and on an upward trend. It has increased from 44.00 Cr. (Mar 2025) to 46.00 Cr., marking an increase of 2.00 Cr..
- For Total Assets, as of Sep 2025, the value is 2,962.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,842.00 Cr. (Mar 2025) to 2,962.00 Cr., marking an increase of 120.00 Cr..
Notably, the Reserves (2,831.00 Cr.) exceed the Borrowings (1.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -11.00 | -11.00 | -1.00 | -2.00 | -2.00 | -3.00 | -2.00 | -3.00 | -3.00 | -3.00 | -3.00 | -4.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | -0 | -0 | -0 | -0 | -0 | -0 | 3 | -0 | ||||
| Inventory Days | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | ||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | -0 | -0 | -0 | -0 | -0 | -0 | 3 | -0 | ||||
| Working Capital Days | -692 | -1,982 | 24,772 | 6,680 | 4,434 | 17 | -11 | -6 | ||||
| ROCE % | 2% | 3% | 4% | 1% | 1% | 1% | 1% | 1% | 2% | 1% | 1% | 0% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 0.04 | 5.55 | 5.64 | 7.85 | 3.52 |
| Diluted EPS (Rs.) | 0.04 | 5.55 | 5.64 | 7.85 | 3.52 |
| Cash EPS (Rs.) | 0.14 | 5.67 | 5.73 | 7.86 | 3.52 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 373.37 | 277.58 | 410.17 | 436.48 | 369.50 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 394.22 | 298.43 | 431.02 | 457.33 | 390.35 |
| Dividend / Share (Rs.) | 0.50 | 5.70 | 6.50 | 5.65 | 3.40 |
| Revenue From Operations / Share (Rs.) | 16.03 | 7.28 | 0.21 | 0.17 | 0.11 |
| PBDIT / Share (Rs.) | 0.33 | 5.72 | 5.78 | 7.76 | 3.37 |
| PBIT / Share (Rs.) | 0.22 | 5.60 | 5.70 | 7.76 | 3.36 |
| PBT / Share (Rs.) | 0.03 | 5.60 | 5.70 | 7.76 | 3.36 |
| Net Profit / Share (Rs.) | 0.04 | 5.55 | 5.64 | 7.85 | 3.52 |
| PBDIT Margin (%) | 2.06 | 78.53 | 2732.78 | 4417.35 | 2813.99 |
| PBIT Margin (%) | 1.38 | 76.89 | 2691.84 | 4414.67 | 2809.84 |
| PBT Margin (%) | 0.20 | 76.89 | 2691.84 | 4414.67 | 2809.84 |
| Net Profit Margin (%) | 0.24 | 76.24 | 2664.95 | 4469.11 | 2936.36 |
| Return on Networth / Equity (%) | 0.01 | 2.00 | 1.37 | 1.79 | 0.95 |
| Return on Capital Employeed (%) | 0.05 | 1.87 | 1.28 | 1.63 | 0.84 |
| Return On Assets (%) | 0.00 | 1.85 | 1.26 | 1.65 | 0.88 |
| Asset Turnover Ratio (%) | 0.04 | 0.01 | 0.00 | 0.00 | 0.00 |
| Current Ratio (X) | 8.83 | 23.44 | 50.39 | 100.10 | 229.58 |
| Quick Ratio (X) | 8.83 | 23.44 | 50.39 | 100.10 | 229.58 |
| Dividend Payout Ratio (NP) (%) | 14244.01 | 117.06 | 100.17 | 43.30 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 3837.47 | 114.59 | 98.65 | 43.27 | 0.00 |
| Earning Retention Ratio (%) | -14144.01 | -17.06 | -0.17 | 56.70 | 0.00 |
| Cash Earning Retention Ratio (%) | -3737.47 | -14.59 | 1.35 | 56.73 | 0.00 |
| Interest Coverage Ratio (X) | 1.75 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (Post Tax) (X) | 1.21 | 0.00 | 0.00 | 0.00 | 0.00 |
| Enterprise Value (Cr.) | 1068.15 | 884.06 | 1038.32 | 913.70 | 586.13 |
| EV / Net Operating Revenue (X) | 9.58 | 17.46 | 705.43 | 747.83 | 703.89 |
| EV / EBITDA (X) | 464.68 | 22.23 | 25.81 | 16.93 | 25.01 |
| MarketCap / Net Operating Revenue (X) | 9.72 | 18.39 | 727.16 | 753.35 | 709.07 |
| Retention Ratios (%) | -14144.01 | -17.06 | -0.17 | 56.69 | 0.00 |
| Price / BV (X) | 0.41 | 0.48 | 0.37 | 0.30 | 0.22 |
| Price / Net Operating Revenue (X) | 9.72 | 18.39 | 727.32 | 753.70 | 709.87 |
| EarningsYield | 0.00 | 0.04 | 0.03 | 0.05 | 0.04 |
After reviewing the key financial ratios for Uniphos Enterprises Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has decreased from 5.55 (Mar 24) to 0.04, marking a decrease of 5.51.
- For Diluted EPS (Rs.), as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has decreased from 5.55 (Mar 24) to 0.04, marking a decrease of 5.51.
- For Cash EPS (Rs.), as of Mar 25, the value is 0.14. This value is below the healthy minimum of 3. It has decreased from 5.67 (Mar 24) to 0.14, marking a decrease of 5.53.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 373.37. It has increased from 277.58 (Mar 24) to 373.37, marking an increase of 95.79.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 394.22. It has increased from 298.43 (Mar 24) to 394.22, marking an increase of 95.79.
- For Dividend / Share (Rs.), as of Mar 25, the value is 0.50. This value is below the healthy minimum of 1. It has decreased from 5.70 (Mar 24) to 0.50, marking a decrease of 5.20.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 16.03. It has increased from 7.28 (Mar 24) to 16.03, marking an increase of 8.75.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 0.33. This value is below the healthy minimum of 2. It has decreased from 5.72 (Mar 24) to 0.33, marking a decrease of 5.39.
- For PBIT / Share (Rs.), as of Mar 25, the value is 0.22. This value is within the healthy range. It has decreased from 5.60 (Mar 24) to 0.22, marking a decrease of 5.38.
- For PBT / Share (Rs.), as of Mar 25, the value is 0.03. This value is within the healthy range. It has decreased from 5.60 (Mar 24) to 0.03, marking a decrease of 5.57.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.04. This value is below the healthy minimum of 2. It has decreased from 5.55 (Mar 24) to 0.04, marking a decrease of 5.51.
- For PBDIT Margin (%), as of Mar 25, the value is 2.06. This value is below the healthy minimum of 10. It has decreased from 78.53 (Mar 24) to 2.06, marking a decrease of 76.47.
- For PBIT Margin (%), as of Mar 25, the value is 1.38. This value is below the healthy minimum of 10. It has decreased from 76.89 (Mar 24) to 1.38, marking a decrease of 75.51.
- For PBT Margin (%), as of Mar 25, the value is 0.20. This value is below the healthy minimum of 10. It has decreased from 76.89 (Mar 24) to 0.20, marking a decrease of 76.69.
- For Net Profit Margin (%), as of Mar 25, the value is 0.24. This value is below the healthy minimum of 5. It has decreased from 76.24 (Mar 24) to 0.24, marking a decrease of 76.00.
- For Return on Networth / Equity (%), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 15. It has decreased from 2.00 (Mar 24) to 0.01, marking a decrease of 1.99.
- For Return on Capital Employeed (%), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 10. It has decreased from 1.87 (Mar 24) to 0.05, marking a decrease of 1.82.
- For Return On Assets (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 1.85 (Mar 24) to 0.00, marking a decrease of 1.85.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.04. It has increased from 0.01 (Mar 24) to 0.04, marking an increase of 0.03.
- For Current Ratio (X), as of Mar 25, the value is 8.83. This value exceeds the healthy maximum of 3. It has decreased from 23.44 (Mar 24) to 8.83, marking a decrease of 14.61.
- For Quick Ratio (X), as of Mar 25, the value is 8.83. This value exceeds the healthy maximum of 2. It has decreased from 23.44 (Mar 24) to 8.83, marking a decrease of 14.61.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 14,244.01. This value exceeds the healthy maximum of 50. It has increased from 117.06 (Mar 24) to 14,244.01, marking an increase of 14,126.95.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 3,837.47. This value exceeds the healthy maximum of 50. It has increased from 114.59 (Mar 24) to 3,837.47, marking an increase of 3,722.88.
- For Earning Retention Ratio (%), as of Mar 25, the value is -14,144.01. This value is below the healthy minimum of 40. It has decreased from -17.06 (Mar 24) to -14,144.01, marking a decrease of 14,126.95.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is -3,737.47. This value is below the healthy minimum of 40. It has decreased from -14.59 (Mar 24) to -3,737.47, marking a decrease of 3,722.88.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 1.75. This value is below the healthy minimum of 3. It has increased from 0.00 (Mar 24) to 1.75, marking an increase of 1.75.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.21. This value is below the healthy minimum of 3. It has increased from 0.00 (Mar 24) to 1.21, marking an increase of 1.21.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,068.15. It has increased from 884.06 (Mar 24) to 1,068.15, marking an increase of 184.09.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 9.58. This value exceeds the healthy maximum of 3. It has decreased from 17.46 (Mar 24) to 9.58, marking a decrease of 7.88.
- For EV / EBITDA (X), as of Mar 25, the value is 464.68. This value exceeds the healthy maximum of 15. It has increased from 22.23 (Mar 24) to 464.68, marking an increase of 442.45.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 9.72. This value exceeds the healthy maximum of 3. It has decreased from 18.39 (Mar 24) to 9.72, marking a decrease of 8.67.
- For Retention Ratios (%), as of Mar 25, the value is -14,144.01. This value is below the healthy minimum of 30. It has decreased from -17.06 (Mar 24) to -14,144.01, marking a decrease of 14,126.95.
- For Price / BV (X), as of Mar 25, the value is 0.41. This value is below the healthy minimum of 1. It has decreased from 0.48 (Mar 24) to 0.41, marking a decrease of 0.07.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 9.72. This value exceeds the healthy maximum of 3. It has decreased from 18.39 (Mar 24) to 9.72, marking a decrease of 8.67.
- For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 24) to 0.00, marking a decrease of 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Uniphos Enterprises Ltd:
- Net Profit Margin: 0.24%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 0.05% (Industry Average ROCE: 11.73%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0.01% (Industry Average ROE: 22.92%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.21
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 8.83
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 52.4 (Industry average Stock P/E: 391.6)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0.24%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Trading & Distributors | 11, G.I.D.C., Vapi, Valsad District Gujarat 396195 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Arun Chandrasen Ashar | Chairman & Non-Exe.Director |
| Mrs. Sandra Rajnikant Shroff | Managing Director |
| Mrs. Meena Deepak Ved | Independent Director |
| Mr. Jaidev Rajnikant Shroff | Non Executive Director |
| Mr. Prasad Vasudev Paranjape | Independent Director |
| Mr. Suresh Balasubramaniam | Independent Director |
FAQ
What is the intrinsic value of Uniphos Enterprises Ltd?
Uniphos Enterprises Ltd's intrinsic value (as of 27 December 2025) is 1.72 which is 98.80% lower the current market price of 143.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 995 Cr. market cap, FY2025-2026 high/low of 173/123, reserves of ₹2,831 Cr, and liabilities of 2,962 Cr.
What is the Market Cap of Uniphos Enterprises Ltd?
The Market Cap of Uniphos Enterprises Ltd is 995 Cr..
What is the current Stock Price of Uniphos Enterprises Ltd as on 27 December 2025?
The current stock price of Uniphos Enterprises Ltd as on 27 December 2025 is 143.
What is the High / Low of Uniphos Enterprises Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Uniphos Enterprises Ltd stocks is 173/123.
What is the Stock P/E of Uniphos Enterprises Ltd?
The Stock P/E of Uniphos Enterprises Ltd is 52.4.
What is the Book Value of Uniphos Enterprises Ltd?
The Book Value of Uniphos Enterprises Ltd is 409.
What is the Dividend Yield of Uniphos Enterprises Ltd?
The Dividend Yield of Uniphos Enterprises Ltd is 0.35 %.
What is the ROCE of Uniphos Enterprises Ltd?
The ROCE of Uniphos Enterprises Ltd is 0.06 %.
What is the ROE of Uniphos Enterprises Ltd?
The ROE of Uniphos Enterprises Ltd is 0.01 %.
What is the Face Value of Uniphos Enterprises Ltd?
The Face Value of Uniphos Enterprises Ltd is 2.00.